Euroaspire V. European Survey of Cardiovascular Disease Prevention and Diabetes

Euroaspire V. European Survey of Cardiovascular Disease Prevention and Diabetes - EUROASPIRE V

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45416

Enrollment

350

Registered

2017-02-01

Start date

2016-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Cardiovascular disease

Prevention

Prognosis

Risk factors

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients

Exclusion criteria

Exclusion criteria: Hospital admission > 2 years ago

Design outcomes

Primary

Measure	Time frame
To evaluate the proportion of patients achieving European lifestyle, risk factors and therapeutic targets for cardiovascular disease prevention. To evaluate the management of risk in terms of lifestyle intervention and the use of drug therapies in relation to those defined in the most recent (2016) European guidelines on cardiovascular disease prevention,	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)